Perphenazine
- Generic Name
- Perphenazine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H26ClN3OS
- CAS Number
- 58-39-9
- Unique Ingredient Identifier
- FTA7XXY4EZ
- Background
An antipsychotic phenothiazine derivative with actions and uses similar to those of chlorpromazine.
- Indication
For use in the management of the manifestations of psychotic disorders and for the control of severe nausea and vomiting in adults.
- Associated Conditions
- Anxiety, Depression, Schizophrenia, Moderate Agitation, Moderate Anxiety, Moderate Depressed mood, Severe Anxiety, Severe Depressed mood, Severe Nausea and vomiting, Severe agitation
- Associated Therapies
- -
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
- Conditions
- Interventions
- First Posted Date
- 2008-12-04
- Last Posted Date
- 2013-02-08
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 21
- Registration Number
- NCT00802100
- Locations
- 🇺🇸
Medical College of Georgia, Augusta, Georgia, United States
🇺🇸University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸SHANTI Clinical Trials, Colton, California, United States
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2012-09-07
- Lead Sponsor
- Paul Saenger
- Target Recruit Count
- 44
- Registration Number
- NCT00737256
- Locations
- 🇺🇸
Veteran's Affairs Medical Center, Denver, Colorado, United States
A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer
- Conditions
- First Posted Date
- 2007-05-30
- Last Posted Date
- 2009-07-21
- Lead Sponsor
- BioLineRx, Ltd.
- Registration Number
- NCT00480246
- Locations
- 🇸🇪
Quintiles Phase I facility, Uppsala, Sweden
CATIE- Schizophrenia Trial
- Conditions
- First Posted Date
- 2001-04-09
- Last Posted Date
- 2015-06-17
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 1600
- Registration Number
- NCT00014001
- Locations
- 🇺🇸
Staten Island University Hospital, Staten Island, New York, United States
🇺🇸Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸Northwestern Medical School Department of Psychiatry, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.